Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Eric Chi

Showing results (1-10 of 37) with videos related to

Pageof 4
Sort By:
Springerplus|July 8, 2016
How to innovate and make successful businessEric Chi-Ming Yim
Journal of Biopharmaceutical Statistics|November 1, 2014
Preface: issues in biosimilar drug developmentBin Yao, Eric Chi
The American Journal of Medicine|December 7, 2007
Anti-TNF antibodies associated with different risk of latent tuberculosis activationMichele Hooper, Eric Chi
Journal of Biopharmaceutical Statistics|January 16, 2010
Biologic drug productsJen-Pei Liu, Eric Chi
Statistics in Medicine|November 30, 2004
Statistical consideration of the strategy for demonstrating clinical evidence of effectiveness--one larger vs two smaller pivotal studiesZhenming Shun, Eric Chi, Sylvain Durrleman, et al.
Statistics in Medicine|July 14, 2011
Modeling subject-specific phase-dependent effects and variations in longitudinal responses via a geometric Brownian motion processLi Zhu, Fushing Hsieh, Juan Li, et al.
Journal of Biopharmaceutical Statistics|July 19, 2014
Nonparametric tests for evaluation of biosimilarity in variability of follow-on biologicsNan Zhang, Jun Yang, Shein-Chung Chow, et al.
Statistics in Medicine|August 31, 2012
An adapted F-test for homogeneity of variability in follow-on biological productsJun Yang, Nan Zhang, Shein-Chung Chow, et al.
Journal of Biomolecular NMR|May 18, 2006
NMR assignment of the phosphotyrosine binding (PTB) domain of tensinMarilisa Leone, Eric Chi-Wang Yu, Robert Liddington, et al.
Journal of Biopharmaceutical Statistics|January 16, 2010
A comparison of moment-based and probability-based criteria for assessment of follow-on biologicsShein-Chung Chow, Tsung-Cheng Hsieh, Eric Chi, et al.
Pageof 4

Showing results (1-10 of 37) with videos related to

Sort By:
Pageof 4
Springerplus|July 8, 2016
How to innovate and make successful businessEric Chi-Ming Yim
Journal of Biopharmaceutical Statistics|November 1, 2014
Preface: issues in biosimilar drug developmentBin Yao, Eric Chi
The American Journal of Medicine|December 7, 2007
Anti-TNF antibodies associated with different risk of latent tuberculosis activationMichele Hooper, Eric Chi
Journal of Biopharmaceutical Statistics|January 16, 2010
Biologic drug productsJen-Pei Liu, Eric Chi
Statistics in Medicine|November 30, 2004
Statistical consideration of the strategy for demonstrating clinical evidence of effectiveness--one larger vs two smaller pivotal studiesZhenming Shun, Eric Chi, Sylvain Durrleman, et al.
Statistics in Medicine|July 14, 2011
Modeling subject-specific phase-dependent effects and variations in longitudinal responses via a geometric Brownian motion processLi Zhu, Fushing Hsieh, Juan Li, et al.
Journal of Biopharmaceutical Statistics|July 19, 2014
Nonparametric tests for evaluation of biosimilarity in variability of follow-on biologicsNan Zhang, Jun Yang, Shein-Chung Chow, et al.
Statistics in Medicine|August 31, 2012
An adapted F-test for homogeneity of variability in follow-on biological productsJun Yang, Nan Zhang, Shein-Chung Chow, et al.
Journal of Biomolecular NMR|May 18, 2006
NMR assignment of the phosphotyrosine binding (PTB) domain of tensinMarilisa Leone, Eric Chi-Wang Yu, Robert Liddington, et al.
Journal of Biopharmaceutical Statistics|January 16, 2010
A comparison of moment-based and probability-based criteria for assessment of follow-on biologicsShein-Chung Chow, Tsung-Cheng Hsieh, Eric Chi, et al.
Pageof 4